Covid-19 drug

WHO temporarily pauses hydroxychloroquine study due to safety concerns
By CNN | 2 years ago
Decision made after an observational study described how seriously ill Covid-19 patients treated with drug were more likely to die....
![WHO on Monday, March 16, 2021 appealed to countries to keep vaccination campaigns going. [PHOTO | FILE]](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_441,h_250/https://www.k24tv.co.ke/wp-content/uploads/2020/04/VACCINE-480x272.jpg)
Gilead strikes deal to make remdesivir coronavirus treatment in 127 countries
By BBC | 2 years ago
This month both the US and Japan authorised remdesivir as a treatment for Covid-19 patients....
Load More please wait....